{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:35:11Z","timestamp":1782484511660,"version":"3.54.5"},"reference-count":28,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computational and Mathematical Methods in Medicine"],"published-print":{"date-parts":[[2022,2,16]]},"abstract":"<jats:p>Objective. To explore the effect of autologous stem cell transplantation combined with modified VTD regimen on elderly patients with multiple myeloma and its influence on miRNA cytokines. Methods. The data of 42 elderly patients with multiple myeloma who were treated in our hospital from May 2010 to June 2018 were retrospectively analyzed, and they were divided into the combined group (autologous stem cell transplantation combined with improved VTD scheme, <jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>n<\/a:mi>\n                        <a:mo>=<\/a:mo>\n                        <a:mn>25<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula>) and the control group (improved VTD scheme, <jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>n<\/c:mi>\n                        <c:mo>=<\/c:mo>\n                        <c:mn>17<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula>) according to different treatment schemes, and the clinical efficacy of the two groups was compared. The levels of CD3+, CD4+, CD4+\/CD8+, and Treg were measured in the two groups. The expression levels of miRNA-15a, miRNA-16, and miRNA-21 in the bone marrow fluid of the two groups were measured before and after treatment. The levels of M protein and myeloma cells in the two groups were detected. Comparing the incidence of adverse reactions between the two groups, the Kaplan-Meier method was used for survival analysis. Results. The total effective rate of the combined group (84.00%) was higher than that of the control group (52.94%), and the difference was statistically significant (<jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&lt;<\/e:mo>\n                        <e:mn>0.05<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>). After treatment, the levels of CD3+, CD4+, CD4+\/CD8+, Treg, miRNA-15a, and miRNA-16 in the combined group were higher than those in the control group, and the levels of miRNA-21, M protein, and myeloma cells were lower than those in the control group, with statistical significance (<jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.05<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula>). There was no significant difference in adverse reactions between the two groups (<jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>&gt;<\/i:mo>\n                        <i:mn>0.05<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula>). The first, second, and third year survival rates of group A (96.00%, 88.00%, and 80.00%) were significantly higher than those of the control group (70.59%, 58.82%, and 47.06%), and the difference was statistically significant (<jats:inline-formula>\n                     <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>P<\/k:mi>\n                        <k:mo>&lt;<\/k:mo>\n                        <k:mn>0.05<\/k:mn>\n                     <\/k:math>\n                  <\/jats:inline-formula>). Conclusion. Autologous stem cell transplantation combined with a modified VTD regimen can effectively improve the immune function and survival rate of elderly patients with multiple myeloma, which is safe and effective.<\/jats:p>","DOI":"10.1155\/2022\/6320329","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T02:05:16Z","timestamp":1645063516000},"page":"1-8","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Autologous Stem Cell Transplantation Combined with Modified VTD Regimen on Elderly Patients with Multiple Myeloma and Its Influence on miRNA Cytokines"],"prefix":"10.1155","volume":"2022","author":[{"given":"Zhaoliang","family":"Bai","sequence":"first","affiliation":[{"name":"Outpatient Department, 971 Hospital of the Chinese People\u2019s Liberation Army Navy, Qingdao, Shandong 266000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-7986","authenticated-orcid":true,"given":"Jiansong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine and Physiotherapy, 971 Hospital of the Chinese People\u2019s Liberation Army Navy, Qingdao, Shandong 266000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2017.05.012"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.5644\/ama2006-124.242"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-1-58"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2016.0470"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.20.04145-2"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12590"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1393668"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.01.003"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0298-1"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04404-3"},{"key":"11","volume-title":"Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-020-00291-4"},{"key":"13","first-page":"5343","article-title":"Expression level of miRNA in the peripheral blood of patients with multiple myeloma and its clinical significance","volume":"13","author":"L. Guangbao","year":"2021","journal-title":"American Journal of Transational Research"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0606"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0852"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25791"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.7534\/j.issn.1009-2137.2017.01.055"},{"issue":"16","key":"18","article-title":"The role and mechanism of bone marrow stromal cells regulating miRNA-15a\/-16 expression in drug resistance of myeloma cells","volume":"92","author":"Z. Meirong","year":"2012","journal-title":"Chinese Journal of Medicine"},{"issue":"12","key":"19","first-page":"1066","article-title":"Guidelines for diagnosis and treatment of multiple myeloma in China","volume":"54","author":"Hematology Branch of Chinese Medical Association, Hematology Branch of Chinese Medical Association, Multiple Myeloma Professional Committee of Chinese Medical Association","year":"2015","journal-title":"Chinese Journal of Internal Medicine"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1177\/1740774520975120"},{"key":"21","volume-title":"Diagnostic and Therapeutic Criteria of Hematologic Diseases","author":"Z. Zhi-nan","year":"2007","edition":"3 Edition"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1513487"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12641"},{"issue":"24","key":"24","article-title":"Comparative observation of PAD regimen and autologous hematopoietic stem cell transplantation for consolidation treatment of newly diagnosed multiple myeloma","volume":"59","author":"J. Ran","year":"2019","journal-title":"Shandong Medicine"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0649"},{"issue":"9","key":"26","article-title":"Expression and clinical significance of miRNA-21, miRNA-15a and miRNA-16 in bone marrow fluid of patients with multiple myeloma","volume":"19","author":"L. Wang","year":"2015","journal-title":"chinese journal of laboratory diagnosis"},{"issue":"12","key":"27","article-title":"Efficacy and nursing of adverse reactions of bortezomib subcutaneous injection in the treatment of multiple myeloma","volume":"24","author":"X. Wang Xun","year":"2018","journal-title":"Chinese Journal of Modern Nursing"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10929"}],"updated-by":[{"DOI":"10.1155\/2023\/9861758","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"record-id":"59883"},{"DOI":"10.1155\/2023\/9861758","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000}}],"container-title":["Computational and Mathematical Methods in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/6320329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/6320329.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/6320329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T02:05:25Z","timestamp":1645063525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/cmmm\/2022\/6320329\/"}},"subtitle":[],"editor":[{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":28,"alternative-id":["6320329","6320329"],"URL":"https:\/\/doi.org\/10.1155\/2022\/6320329","relation":{"retraction":[{"id-type":"doi","id":"10.1155\/2023\/9861758","asserted-by":"object"}]},"ISSN":["1748-6718","1748-670X"],"issn-type":[{"value":"1748-6718","type":"electronic"},{"value":"1748-670X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}